These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
187 related articles for article (PubMed ID: 35786618)
1. Will Proton Pump Inhibitors Increase the Risk of Diabetes Mellitus? A Systemic Review and Meta-Analysis. Chen Y; Hu L; Sun C; Bao J; Liu J; Bhan C; Kim KY; Manem R; Thapa P; Ma S; Liu M; Cheng X; Cheng C; Zhou Q Turk J Gastroenterol; 2022 Jun; 33(6):497-504. PubMed ID: 35786618 [TBL] [Abstract][Full Text] [Related]
2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas. Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557 [TBL] [Abstract][Full Text] [Related]
3. Proton pump inhibitors use and dementia risk: a meta-analysis of cohort studies. Zhang Y; Liang M; Sun C; Song EJ; Cheng C; Shi T; Min M; Sun Y Eur J Clin Pharmacol; 2020 Feb; 76(2):139-147. PubMed ID: 31748819 [TBL] [Abstract][Full Text] [Related]
4. Proton pump inhibitors therapy and risk of Clostridium difficile infection: Systematic review and meta-analysis. Trifan A; Stanciu C; Girleanu I; Stoica OC; Singeap AM; Maxim R; Chiriac SA; Ciobica A; Boiculese L World J Gastroenterol; 2017 Sep; 23(35):6500-6515. PubMed ID: 29085200 [TBL] [Abstract][Full Text] [Related]
5. Association and Mechanisms of Proton Pump Inhibitors Use with Type-2Diabetes Mellitus Incidence in Adults: A Systemic Review andMeta-Analysis. Chenchula S; Sharma P; Ghanta MK; Amerneni KC; Rajakarunakaran P; Saggurthi P; Chandra MB; Gupta R; Chavan M Curr Diabetes Rev; 2024; 20(10):e120124225581. PubMed ID: 38243950 [TBL] [Abstract][Full Text] [Related]
6. Exposure to proton pump inhibitors and risk of diabetes: A systematic review and meta-analysis. Guo YR; Liu XM; Wang GX World J Diabetes; 2023 Feb; 14(2):120-129. PubMed ID: 36926660 [TBL] [Abstract][Full Text] [Related]
8. The Safety of Long-Term Proton Pump Inhibitor Use on Cardiovascular Health: A Meta-Analysis. Jeridi D; Pellat A; Ginestet C; Assaf A; Hallit R; Corre F; Coriat R J Clin Med; 2022 Jul; 11(14):. PubMed ID: 35887860 [TBL] [Abstract][Full Text] [Related]
9. Interventions for preventing upper gastrointestinal bleeding in people admitted to intensive care units. Toews I; George AT; Peter JV; Kirubakaran R; Fontes LES; Ezekiel JPB; Meerpohl JJ Cochrane Database Syst Rev; 2018 Jun; 6(6):CD008687. PubMed ID: 29862492 [TBL] [Abstract][Full Text] [Related]
10. The association between the use of proton pump inhibitors and the risk of hypomagnesemia: a systematic review and meta-analysis. Park CH; Kim EH; Roh YH; Kim HY; Lee SK PLoS One; 2014; 9(11):e112558. PubMed ID: 25394217 [TBL] [Abstract][Full Text] [Related]
11. Associations of Proton-Pump Inhibitors and H2 Receptor Antagonists with Chronic Kidney Disease: A Meta-Analysis. Wijarnpreecha K; Thongprayoon C; Chesdachai S; Panjawatanana P; Ungprasert P; Cheungpasitporn W Dig Dis Sci; 2017 Oct; 62(10):2821-2827. PubMed ID: 28836158 [TBL] [Abstract][Full Text] [Related]
12. Gastric Cancer Risk in Patients with Long-Term Use of Proton Pump Inhibitors: A Systematic Review and Meta-Analysis of Observational and Interventional Studies. Pan S; Thrift AP; Akhdar G; El-Serag HB Dig Dis Sci; 2023 Sep; 68(9):3732-3744. PubMed ID: 37432532 [TBL] [Abstract][Full Text] [Related]
13. Proton pump inhibitor use increases hepatic encephalopathy risk: A systematic review and meta-analysis. Ma YJ; Cao ZX; Li Y; Feng SY World J Gastroenterol; 2019 Jun; 25(21):2675-2682. PubMed ID: 31210718 [TBL] [Abstract][Full Text] [Related]
14. Diabetic dyslipidemia and its predictors among people with diabetes in Ethiopia: systematic review and meta-analysis. Azagew AW; Abate HK; Mekonnen CK; Mekonnen HS; Tezera ZB; Jember G Syst Rev; 2024 Jul; 13(1):190. PubMed ID: 39033198 [TBL] [Abstract][Full Text] [Related]
15. Proton pump inhibitor use and risk of dementia: Systematic review and meta-analysis. Li M; Luo Z; Yu S; Tang Z Medicine (Baltimore); 2019 Feb; 98(7):e14422. PubMed ID: 30762748 [TBL] [Abstract][Full Text] [Related]
16. The association between proton pump inhibitor use and systemic anti-tumour therapy on survival outcomes in patients with advanced non-small cell lung cancer: A systematic review and meta-analysis. Wei N; Zheng B; Que W; Zhang J; Liu M Br J Clin Pharmacol; 2022 Jul; 88(7):3052-3063. PubMed ID: 35165922 [TBL] [Abstract][Full Text] [Related]
17. Adverse cardiovascular outcomes associated with proton pump inhibitor use after percutaneous coronary intervention: a systematic review and meta-analysis. Padhi BK; Khatib MN; Zahiruddin QS; Rustagi S; Sharma RK; Sah R; Satapathy P; Rao AP BMC Cardiovasc Disord; 2024 Jul; 24(1):372. PubMed ID: 39020285 [TBL] [Abstract][Full Text] [Related]
18. Vitamin B12 deficiency and use of proton pump inhibitors: a systematic review and meta-analysis. Choudhury A; Jena A; Jearth V; Dutta AK; Makharia G; Dutta U; Goenka M; Kochhar R; Sharma V Expert Rev Gastroenterol Hepatol; 2023 May; 17(5):479-487. PubMed ID: 37060552 [TBL] [Abstract][Full Text] [Related]
19. Association between proton-pump inhibitors and the risk of gastric cancer: a systematic review and meta-analysis. Peng TR; Wu TW; Li CH Int J Clin Oncol; 2023 Jan; 28(1):99-109. PubMed ID: 36224477 [TBL] [Abstract][Full Text] [Related]
20. Proton pump inhibitors and the risk of colorectal cancer: a systematic review and meta-analysis of observational studies. Ma T; Wu M; Jia S; Yang L Int J Colorectal Dis; 2020 Dec; 35(12):2157-2169. PubMed ID: 32808072 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]